Cargando…
Genetically modified mesenchymal stromal cells in cancer therapy
The cell therapy industry has grown rapidly over the past 3 decades, and multiple clinical trials have been performed to date covering a wide range of diseases. The most frequently used cell is mesenchymal stromal cells (MSCs), which have been used largely for their anti-inflammatory actions and in...
Autores principales: | Sage, Elizabeth K., Thakrar, Ricky M., Janes, Sam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082580/ https://www.ncbi.nlm.nih.gov/pubmed/27745603 http://dx.doi.org/10.1016/j.jcyt.2016.09.003 |
Ejemplares similares
-
Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy
por: Yuan, Zhengqiang, et al.
Publicado: (2016) -
The promises and challenges of early non‐small cell lung cancer detection: patient perceptions, low‐dose CT screening, bronchoscopy and biomarkers
por: Kalinke, Lukas, et al.
Publicado: (2020) -
Mesenchymal stromal cell delivery of full-length tumor necrosis factor–related apoptosis-inducing ligand is superior to soluble type for cancer therapy
por: Yuan, ZhengQiang, et al.
Publicado: (2015) -
Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ
por: Reagan, Michaela R., et al.
Publicado: (2012) -
Mesenchymal Stem Cells as Vectors for Lung Cancer Therapy
por: Kolluri, Krishna K., et al.
Publicado: (2013)